Previous studies have demonstrated that mutations in the paraoxonase (PON) gene family polymorphisms act as protective factors against coronary heart disease, with a 7% decrease in prevalence in patients with coronary heart disease compared to control subjects [45]. Here, PON1 is linked to coronary artery disorder.